Inflammasome inhibitors: promising therapeutic approaches against cancer
Abstract Inflammation has long been accepted as a key component of carcinogenesis. During inflammation, inflammasomes are potent contributors to the activation of inflammatory cytokines that lead to an inflammatory cascade. Considering the contributing role of inflammasomes in cancer progression, in...
Main Authors: | Shengchao Xu, Xizhe Li, Yuanqi Liu, Yu Xia, Ruimin Chang, Chunfang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-019-0755-0 |
Similar Items
-
Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives
by: Norina Vinţeler, et al.
Published: (2024-01-01) -
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
by: Biswadeep Das, et al.
Published: (2021-08-01) -
Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
by: Gaber El-Saber Batiha, et al.
Published: (2022-11-01) -
NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
by: Mahbuba Akther, et al.
Published: (2021-08-01) -
Dysregulation of inflammasome activation in glioma
by: JeongMin Sim, et al.
Published: (2023-09-01)